This clinical lab conference spotlight looks at why ADLM 2026 belongs on the radar for CLP readers. From the scientific program to the Clinical Lab Expo, the event offers practical ideas, fresh technology, and real conversations for people working across diagnostics and laboratory medicine. For lab professionals who want useful insight, sharper perspective, and stronger industry connections, this is a smart place to be.
CLP spoke with Peggy Lillis Foundation CEO Christian Lillis on raising C. diff awareness to improve diagnostics and public understanding.
In this episode of Clinical Lab Chat, Seth Egan of Co-Diagnostics discusses how POC testing improves both diagnostic and treatment access.
In this episode of Clinical Lab Chat, we presented the CEO of Senzo a challenge—is it possible to create a “perfect” diagnostic test?
Read More
Avalon Healthcare Solutions’ Lab Trend Report found the use of genetic testing increased last year, while routine testing remained stable.
Read More
A new study reveals that using minimally invasive blood collection devices can increase involvement of people experiencing homelessness.
Read More
Location, race, and insurance status significantly affect whether cancer patients are diagnosed at an early or late stage.
Read MoreJoin our webinar to learn how aligning clinical and laboratory practices using the Quantra Hemostasis System can dramatically improve management of critical bleeding. Gain insights on viscoelastic testing, rapid identification of acute coagulopathy, and effective team collaboration. Perfect for technicians, lab managers, and healthcare providers.
Read More
In a shift from talking about clinical diagnostics, this episode of Clinical Lab Chat focuses on how laboratory listeners can manage stress.
Read More
After being declared eradicated in the U.S. in 2000, measles has been making a comeback in recent years—the current caseload equals the entire number of cases in 2023.
Read More
CLP’s director of business intelligence, Chris Wolski, sits down with Opentrons CEO Jonathan Brennan-Badal to discuss all things robotic.
Read More
In this episode of Clinical Lab Chat, CLP’s Chris Wolski interviews BD’s Bridget Bagnato about the company’s new MiniDraw technology.
Read More
The newly launched Cancer Screening Research Network (CSRN) will evaluate promising and emerging cancer screening technologies.
Read More
CLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
Read More
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read More
This research could help address challenges in misdiagnosis and treatment of patients, potentially reducing bleeding complication risks.
Read More
In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, engaged in a deep-dive discussion on the burgeoning synergy between omics technologies and precision medicine solutions with Rosy Lee, VP and general manager, Life Sciences Mass Spectrometry, Thermo Fisher Scientific.
Read More
CLP’s Director of Business Intelligence, Chris Wolski, spoke with Judit Giró Benet, co-founder and CEO of The Blue Box, for an in-depth discussion on breast cancer diagnostics, with a focus on non-invasive testing. Topics touched on during their conversation include using urine to identify breast cancer biomarkers; the distinctions between mammographies and liquid biopsies for cancer detection; and more.
Read More